Drug lookup
Drug reference

Folic Acid

Vitamin B9 / folate supplement / hematopoietic · Antianemic, Nutritional Supplement

Also known as Folate, Vitamin B9, Pteroylmonoglutamic acid

START
Confirm B12 status before starting (to avoid masking B12 deficiency); 5 mg OD for deficiency; 400 mcg OD for pregnancy
TYPICAL MAX
5 mg/day standard max
STOP IF
Complete hematological remission (then continue maintenance if indicated)
WATCH
CBC, reticulocyte count (should rise in 5-7 days), B12 levels, homocysteine if indicated
CDSCO approvedOTCJan AushadhiNPPA price-controlledATC B03BB01
Dose laddermg/d
0.4start5ceiling
Renal dose adjustmenteGFR mL/min/1.73m²
FULLNo renal adjustment needed090

KDIGO 2024 + manufacturer label

Pharmacokineticsplasma · t hours
23minONSET1.5hPEAK2h1dDURATION
ONSET
23min · absorption onset
PEAK
1.5h · Peak plasma concentration
2h · Short half-life
DURATION
1d · Daily dosing
EXCRETION
Renal (metabolites)
route + CYP
INTERACTIONS
4 major
SEVERE in our sources
PREGNANCY
Essential in pregnancy; recommended 400-800 mcg/day preconception through first trimester to prevent neural tube defects
FDA category + note
Top interactionssee all 10
  • Vitamin B12SevereTextbookKDT 7e · p610
  • CapecitabineSevereDatabaseDDInter
  • CyanocobalaminSevereDatabaseKimi deep-research + Cla
  • FluorouracilSevereDatabaseDDInter
Available in India

40 branded formulations and 249 fixed-dose combinations. Look up specific brands in the Drugs workspace.

Jan Aushadhi — generic available at GoI pharmacies

Mechanism

Essential cofactor for DNA synthesis, cell division, and amino acid metabolism. Converted to tetrahydrofolate (THF) and then to various coenzyme forms (5-methyl-THF, 10-formyl-THF) required for purine and pyrimidine synthesis, DNA methylation, and homocysteine remethylation to methionine

Indications

Megaloblastic anemia (folate deficiency)Prevention of neural tube defects (preconception and pregnancy)Prevention of folate deficiency in chronic hemolytic anemiaMethotrexate toxicity reduction (folic acid rescue)HyperhomocysteinemiaMethotrexate therapy for rheumatoid arthritis / psoriasis (folic acid supplementation)

Dosing

Adult
Deficiency: 5 mg OD until hematological remission then maintenance 2.5-5 mg OD. Pregnancy/preconception: 400-800 mcg OD (0.4-0.8 mg). MTX rescue: 5 mg once weekly (taken 24h after MTX)
Pediatric
Deficiency: 1-5 mg OD depending on age. NTD prevention: 400 mcg OD
Renal adjustment
No adjustment needed
Hepatic adjustment
No adjustment needed
Geriatric
Standard dosing; ensure B12 status checked before starting
Max dose
5 mg/day (usual max); higher doses under medical supervision

Pharmacokinetics

Onset
Days (hematological response)
Peak effect
1-2 hours (Tmax)
Duration
Variable
Half-life
~1.5 hours (folic acid); 3-5 hours (5-methyl-THF)
Bioavailability
~85-90% (oral)
Protein binding
Low
Metabolism
Hepatic reduction and methylation to active 5-methyltetrahydrofolate
Excretion
Renal (primarily as metabolites and small amounts unchanged)

Contraindications

  • Vitamin B12 deficiency without B12 replacement (may mask anemia while neurological damage progresses)
  • Previous hypersensitivity to folic acid (rare)

Side effects

Common
Nausea (rare at standard doses)AnorexiaBloatingBitter tasteSleep disturbances (rare)
Serious
  • Masking of B12 deficiency (can allow neurological damage to progress)
  • Allergic reactions (rare)
  • Bronchospasm (rare, with injectable form)

Pregnancy & lactation

Pregnancy

Essential in pregnancy; recommended 400-800 mcg/day preconception through first trimester to prevent neural tube defects

Lactation

Excreted in breast milk; compatible with breastfeeding; recommended during lactation

Drug interactions

Vitamin B12
Severe
Textbook

While haematological parameters may improve, neurological defects associated with vitamin B12 deficiency may worsen or become irreversible.

Folic acid should never be given alone to patients with vitamin B12 deficiency. Vitamin B12 must be administered concurrently or prior to folic acid.

Source: KDT 7e · p610

Capecitabine
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Cyanocobalamin
Severe
Database

High-dose folic acid can correct the hematologic abnormalities of B12 deficiency while allowing irreversible neurologic damage (subacute combined degeneration) to progress unchecked.

Never treat megaloblastic anemia with folate alone without first ruling out B12 deficiency. Always check B12 and MMA levels before initiating folate therapy.

Source: Kimi deep-research + Cla

Fluorouracil
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Phenobarbitone
Moderate
Textbook

Phenobarbitone can cause megaloblastic anaemia due to folate deficiency. Folic acid given in large doses can reduce the efficacy of phenobarbitone, increasing seizure risk.

Treat anticonvulsant-induced megaloblastic anaemia with folic acid, but avoid large doses to prevent antagonism of the anticonvulsant effect. Monitor folate levels and seizure control.

Source: KDT 7e · p610

Methotrexate
Moderate
Database

Folic acid reduces methotrexate efficacy at high doses (competes for same transport); at low MTX doses (RA/psoriasis), folic acid reduces toxicity without reducing efficacy

For MTX in RA/psoriasis: give folic acid 5 mg weekly (24h after MTX). For cancer: avoid concurrent use during MTX therapy

Source: Kimi deep-research + Cla

Phenobarbital
Moderate
Database

May increase the frequency of seizures in susceptible children.

Be aware that large amounts of folic acid may counteract the antiepileptic effect of phenobarbital and increase the frequency of seizures.

Source: DDInter

Phenytoin
Moderate
Database

Folic acid may reduce phenytoin levels and seizure control; phenytoin may increase folate requirements

Monitor phenytoin levels; may need dose adjustment

Source: Kimi deep-research + Cla

Primidone
Moderate
Database

May increase the frequency of seizures in susceptible children.

Be aware that large amounts of folic acid may counteract the antiepileptic effect of primidone and increase the frequency of seizures.

Source: DDInter

Trimethoprim
Moderate
Database

Both affect folate metabolism; may have antagonistic effects at high folate doses

Monitor clinical response

Source: Kimi deep-research + Cla

2 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Ask House about Folic Acid

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, Katzung·Verified: 2026-05-19 · House clinical team·Cockpit curated: 2026-05-19